Latest stories on AMPH
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London
PR Newswire53 · neutralproduct/pr
Amphastar price target raised to $23 from $20 at BofA
The Fly64 · neutralanalyst
Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Amphastar (AMPH) Q3 2026 Earnings Call Transcript
The Motley Fool54 · neutralearnings
AMPH Maintains Rating by Wells Fargo -- Price Target Raised to $25
GuruFocus63 · neutralanalyst
Amphastar Pharmaceuticals Reports Q3 Revenue of $207.6 Million and GAAP EPS of $0.87, Both Beating Analyst Estimates
GuruFocus68 · bullishearnings
Amphastar Pharmaceuticals Non-GAAP EPS of $1.14 beats by $0.28, revenue of $207.6M beats by $10.1M
Seeking Alpha72 · bullishearnings
Amphastar Pharmaceuticals, Inc. (AMPH) files 8-K
SEC 8-K50 · neutralgeneral
Amphastar reports Q3 adjusted EPS $1.14, consensus 86c
The Fly74 · bullishearnings
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026
StockTitan50 · neutralearnings
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026
PR Newswire50 · neutralearnings
Amphastar: 2 Years Since My Last Hold Call, I Remain On The Sidelines
Seeking Alpha48 · neutralanalyst
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference
PR Newswire55 · neutralgeneral
Amphastar price target raised to $23 from $20 at Barclays
The Fly61 · neutralanalyst
Amphastar (AMPH) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Amphastar price target raised to $20 from $19 at Wells Fargo
The Fly61 · neutralanalyst
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Amphastar Pharmaceuticals Q2 Earnings Call Highlights
Yahoo Finance56 · neutralearnings
Amphastar reports Q2 adjusted EPS 91c, consensus 61c
The Fly73 · bullishearnings
Amphastar Pharmaceuticals, Inc. (AMPH) files 8-K
SEC 8-K50 · neutralgeneral
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026
PR Newswire59 · neutralearnings
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026
PR Newswire50 · neutralearnings
Amphastar Pharmaceuticals, Inc. (AMPH) files 8-K
SEC 8-K50 · neutralgeneral
Amphastar unit gets FDA warning letter over manufacturing violations
Seeking Alpha38 · neutralgeneral